Terin D’Amico

Biochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Hsp90 β ‐Selective Inhibitors: Probing the Solvent‐Accessible Frontier”.

Hsp90 β ‐Selective Inhibitors: Probing the Solvent‐Accessible Frontier

ChemMedChem(2025)10.1002/cmdc.202500657

N/A

0.104DataRank · unranked

1 citations

Michael A. Serwetnyk, Xiaozheng Dou, Ian Mersich, Deborah Barlow, Karen L. Houseknecht +4 more

Natural products and other inhibitors of F1FO ATP synthase

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112779

N/A

0DataRank · unranked

32 citations

Terin D’Amico, Brian S. J. Blagg, Bhargav A. Patel

CryoEM Structure with ATP Synthase Enables Late‐Stage Diversification of Cruentaren A

Chemistry - A European Journal(2023)10.1002/chem.202300262

N/A

0DataRank · unranked

0 citations

Hui Guo, Terin D’Amico, Leah Abdallah, Chitra Subramanian, Bhargav A. Patel +4 more

Optimization of an Hsp90β-selective inhibitor via exploration of the Hsp90 N-terminal ATP-binding pocket

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.117925

N/A

0DataRank · unranked

9 citations

Taddäus Strunden, Ian Mersich, Deborah Barlow, Terin D’Amico, Sanket J. Mishra +4 more

The Hsp90β Isoform: An Attractive Target for Drug Development

Medicinal Research Reviews(2025)10.1002/med.22114

N/A

0DataRank · unranked

11 citations

Terin D’Amico, Brian S. J. Blagg, Subhabrata Chaudhury